close search

Professor Mark Hogarth

Head, Immune Therapies Group
Making disease treatment more effective with Stellabody® NEWS POST
2023 in Review: July to December NEWS POST
Exciting technology opens the door to new treatments for cancer and infectious diseases NEWS POST